HCW Biologics Inc (NASDAQ:HCWB)’s traded shares stood at 2.36 million during the last session, with the company’s beta value hitting 0.72. At the close of trading, the stock’s price was $0.43, to imply a decrease of -21.18% or -$0.11 in intraday trading. The HCWB share’s 52-week high remains $2.52, putting it -486.05% down since that peak but still an impressive 51.16% since price per share fell to its 52-week low of $0.21. The company has a valuation of $16.22M, with an average of 35.74 million shares in intraday trading volume over the past 10 days and average of 15.58 million shares over the past 3 months.
HCW Biologics Inc (NASDAQ:HCWB) trade information
After registering a -21.18% downside in the last session, HCW Biologics Inc (HCWB) has traded red over the past five days. The 5-day price performance for the stock is 65.50%, and -2.32% over 30 days. With these gigs, the year-to-date price performance is -3.88%. Short interest in HCW Biologics Inc (NASDAQ:HCWB) saw shorts transact 8092.0 shares and set a 0.28 days time to cover.
HCW Biologics Inc (HCWB) estimates and forecasts
The rating firms project that company’s revenue will grow 222.75% compared to the previous financial year.
Revenue forecast for the current quarter as set by 1 analysts is 7M.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -34.57% for the past 5-year period. While 2025 is set for a 18.57% return in earnings, projections for the next 5 years are at 8.29% annually.
HCWB Dividends
HCW Biologics Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
HCW Biologics Inc (NASDAQ:HCWB)’s Major holders
HCW Biologics Inc insiders hold 52.30% of total outstanding shares, with institutional holders owning 3.13% of the shares at 6.56% float percentage. In total, 3.13% institutions holds shares in the company, led by AVANTAX PLANNING PARTNERS, INC.. As of 2024-06-30, the company held over 0.28 million shares (or 0.751% of shares), all amounting to roughly $0.18 million.
The next major institution holding the largest number of shares is HIGHTOWER ADVISORS, LLC with 0.18 million shares, or about 0.4857% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $0.12 million.
We also have Fidelity Extended Market Index Fund and Bridgeway Funds Inc-Ultra Small Company Market Fund as the top two Mutual Funds with the largest holdings of the HCW Biologics Inc (HCWB) shares. Going by data provided on Nov 30, 2024 , Fidelity Extended Market Index Fund holds roughly 94.58 shares. This is just over 0.25% of the total shares, with a market valuation of $40557.0. Data from the same date shows that the other fund manager holds a little less at 84.7, or 0.22% of the shares, all valued at about 36319.0.
